vs
Ascendis Pharma A/S（ASND）与Essex Property Trust（ESS）财务数据对比。点击上方公司名可切换其他公司
Essex Property Trust的季度营收约是Ascendis Pharma A/S的1.8倍（$479.6M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs 5.5%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 6.0%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
Essex Property Trust是一家公开上市的房地产投资信托企业，重点布局美国西海岸优质不动产市场，核心投资标的为加利福尼亚州及西雅图大都会区的公寓类物业，在长租公寓的投资、运营及管理领域拥有深厚的行业积累与资源优势。
ASND vs ESS — 直观对比
营收规模更大
ESS
是对方的1.8倍
$267.3M
营收增速更快
ASND
高出36.8%
5.5%
两年增速更快
ASND
近两年复合增速
6.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $479.6M |
| 净利润 | — | $85.7M |
| 毛利率 | 90.5% | 70.0% |
| 营业利润率 | — | 31.7% |
| 净利率 | — | 17.9% |
| 营收同比 | 42.3% | 5.5% |
| 净利润同比 | — | -71.6% |
| 每股收益（稀释后） | — | $1.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDESS
| Q4 25 | $267.3M | $479.6M | ||
| Q3 25 | $230.7M | $473.3M | ||
| Q2 25 | $170.7M | $469.8M | ||
| Q1 25 | $109.0M | $464.6M | ||
| Q4 24 | $187.8M | $454.5M | ||
| Q3 24 | $62.5M | $450.7M | ||
| Q2 24 | $38.9M | $442.4M | ||
| Q1 24 | $103.6M | $426.9M |
净利润ASNDESS
| Q4 25 | — | $85.7M | ||
| Q3 25 | $-65.9M | $172.7M | ||
| Q2 25 | $-42.0M | $231.5M | ||
| Q1 25 | $-102.2M | $212.8M | ||
| Q4 24 | — | $301.7M | ||
| Q3 24 | $-107.1M | $125.5M | ||
| Q2 24 | $-118.1M | $99.0M | ||
| Q1 24 | $-141.5M | $285.1M |
毛利率ASNDESS
| Q4 25 | 90.5% | 70.0% | ||
| Q3 25 | 89.5% | 69.2% | ||
| Q2 25 | 80.1% | 70.7% | ||
| Q1 25 | 82.6% | 69.6% | ||
| Q4 24 | 91.9% | 70.0% | ||
| Q3 24 | 80.6% | 69.5% | ||
| Q2 24 | 68.2% | 70.8% | ||
| Q1 24 | 92.1% | 69.7% |
营业利润率ASNDESS
| Q4 25 | — | 31.7% | ||
| Q3 25 | 5.1% | 44.5% | ||
| Q2 25 | -33.5% | 59.5% | ||
| Q1 25 | -103.2% | 55.3% | ||
| Q4 24 | — | 67.0% | ||
| Q3 24 | -167.3% | 28.6% | ||
| Q2 24 | -370.2% | 31.1% | ||
| Q1 24 | -51.2% | 31.0% |
净利率ASNDESS
| Q4 25 | — | 17.9% | ||
| Q3 25 | -28.5% | 36.5% | ||
| Q2 25 | -24.6% | 49.3% | ||
| Q1 25 | -93.7% | 45.8% | ||
| Q4 24 | — | 66.4% | ||
| Q3 24 | -171.5% | 27.8% | ||
| Q2 24 | -303.9% | 22.4% | ||
| Q1 24 | -136.6% | 66.8% |
每股收益（稀释后）ASNDESS
| Q4 25 | — | $1.24 | ||
| Q3 25 | — | $2.56 | ||
| Q2 25 | — | $3.44 | ||
| Q1 25 | — | $3.16 | ||
| Q4 24 | — | $4.00 | ||
| Q3 24 | — | $1.84 | ||
| Q2 24 | — | $1.45 | ||
| Q1 24 | — | $4.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $76.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-175.8M | $5.5B |
| 总资产 | $1.4B | $13.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASNDESS
| Q4 25 | $665.3M | $76.2M | ||
| Q3 25 | $582.2M | $66.0M | ||
| Q2 25 | $533.6M | $58.7M | ||
| Q1 25 | $559.4M | $98.7M | ||
| Q4 24 | $604.3M | $66.8M | ||
| Q3 24 | $675.6M | $71.3M | ||
| Q2 24 | $279.4M | $55.2M | ||
| Q1 24 | $345.9M | $499.0M |
总债务ASNDESS
| Q4 25 | — | — | ||
| Q3 25 | — | $6.4B | ||
| Q2 25 | — | $6.4B | ||
| Q1 25 | — | $6.8B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.2B | ||
| Q1 24 | — | $6.6B |
股东权益ASNDESS
| Q4 25 | $-175.8M | $5.5B | ||
| Q3 25 | $-188.0M | $5.6B | ||
| Q2 25 | $-202.6M | $5.6B | ||
| Q1 25 | $-205.0M | $5.6B | ||
| Q4 24 | $-114.2M | $5.5B | ||
| Q3 24 | $-105.1M | $5.4B | ||
| Q2 24 | $-346.8M | $5.5B | ||
| Q1 24 | $-257.2M | $5.5B |
总资产ASNDESS
| Q4 25 | $1.4B | $13.2B | ||
| Q3 25 | $1.2B | $13.2B | ||
| Q2 25 | $1.2B | $13.2B | ||
| Q1 25 | $1.1B | $13.2B | ||
| Q4 24 | $1.3B | $12.9B | ||
| Q3 24 | $1.2B | $12.6B | ||
| Q2 24 | $819.0M | $12.5B | ||
| Q1 24 | $866.7M | $12.9B |
负债/权益比ASNDESS
| Q4 25 | — | — | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.22× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 1.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $1.1B |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 12.53× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASNDESS
| Q4 25 | $58.2M | $1.1B | ||
| Q3 25 | — | $342.6M | ||
| Q2 25 | — | $216.1M | ||
| Q1 25 | $-15.5M | $281.5M | ||
| Q4 24 | $-330.7M | $1.1B | ||
| Q3 24 | — | $316.2M | ||
| Q2 24 | — | $218.9M | ||
| Q1 24 | $-109.7M | $314.9M |
现金转化率ASNDESS
| Q4 25 | — | 12.53× | ||
| Q3 25 | — | 1.98× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 1.32× | ||
| Q4 24 | — | 3.54× | ||
| Q3 24 | — | 2.52× | ||
| Q2 24 | — | 2.21× | ||
| Q1 24 | — | 1.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
